US Pharmaceutical Contract Manufacturing Market Report 2022: Increasing Drug Discovery and Outsourcing of Manufacturing to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Pharmaceutical Contract Manufacturing Market Research and Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering.

The US pharmaceutical contract manufacturing is growing at a considerable CAGR of 4.8% during the forecast period. Rising demand for innovative drug and medical devices is one of the prime factors affecting and driving the market.

Increasing drug discovery and outsourcing of manufacturing along with patent cliffs are also estimated to be the prime factors that are contributing significantly towards the growth of the market. However, rising costs related with logistics along with strict rules and regulations by government are some of the major factors constraints that are hindering the growth of the US pharmaceutical contract manufacturing.

Moreover, offering effective services at low cost is one of the key factors that are creating opportunity for the market. New product launches in the market are likely to drive the growth of the global wheelchair market. For instance, in December 2019, Thermo Fisher Scientific Inc. which is considered as one of the serving science companies had extended its contract development and manufacturing organization (CDMO) in Lexington, Mass.

The company invested around $90 million with 50,000 square foot facility that will offer and support development, testing and manufacturing of viral vectors. Additionally, through this investment the company will add around 200 jobs along with offering a range of services through increasing speed for commercialization of new therapies.

The Report Covers

• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the US pharmaceutical contract manufacturing. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where in the market.

Key Topics Covered:

1. Report Summary

2. Market Overview and Insights

3. Competitive Landscape

4. Market Determinants

5. Market Segmentation

5.1. US Pharmaceutical Contract Manufacturing Market by Category

5.1.1. Human Based Drugs

5.1.2. Animals Based Drugs

5.2. US Pharmaceutical Contract Manufacturing Market by Product

5.2.1. Over-The-Counter (OTC) Drugs

5.2.2. Active Pharmaceutical Ingredients (API)

5.2.3. Finished Dosage Formulation

5.2.4. Other

5.3. The US Pharmaceutical Contract Manufacturing by Services

5.3.1. Manufacturing Services

5.3.2. Non-Clinical Services

5.3.3. Research and Development

6. Company Profiles

Companies Mentioned

• AbbVie Inc.
• Ajinomoto Bio-Pharma
• Catalent, Inc
• Cardinal Health.
• Denison Pharmaceuticals
• Dravon Medical Inc.
• East West Manufacturing
• HISUN USA, inc.
• HTI Plastics
• Hikma Pharmaceuticals PLC
• Lonza Capsules & Health Ingredients
• McGuff Pharmaceuticals, Inc.
• Medix Biochemica
• NEEDLETECH, Corp.
• Nextphase Medical Devices, LLC.
• Nutra Solutions USA
• Nutrafill, LLC
• Pfizer Inc.
• Phoenix Deventures Inc.
• SMC Ltd.
• Stason Pharmaceuticals
• Superior Supplement Manufacturing
• Thermo Fisher Scientific Inc.
• West Pharmaceutical Services, Inc.
• Zoetis

For more information about this report visit https://www.researchandmarkets.com/r/o04xyy

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900